Natera to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, Jan. 9, 2024 at 3:45 p.m. PT (6:45 p.m. ET). Members of Natera's management will deliver a presentation and host a Q&A with the investment community at the conference.
A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.
About Natera
Nateratm is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 180 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.
"Cities Computing on the Edge" is coming to New York City. Urban environments are constantly evolving and cities need to invest in and implement sustainable ways of living to address new urban challenges and improve the quality of life of their...
The Ministère de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs (MELCCFP) and the California Air Resources Board (CARB) announce that due to technical issues with the transactional Web platform, the joint...
Gong, the Revenue Intelligence leader, today announced the winners of the 2024 Golden Gong Awards. The awards recognize companies that are using Gong's AI-powered platform to innovate and transform their revenue organizations, boost productivity, and...
In today's hyper-competitive business landscape, the ability to execute effective campaign planning can make all the difference between success and failure. Leading analytics firm Quantzig has recently released a comprehensive case study, offering...
Radiate Holdco, LLC ("Radiate") announced today that it released its First Quarter 2024 financial results on its secure investor website. The financial results were provided in accordance with the terms of the Indentures governing Radiate's 4.5%...
